In head and neck squamous cell carcinoma (HNSCC) cells, EGF has been shown to function as an upstream factor of CXCL14, and the EGFR tyrosine kinase inhibitor can restore CXCL14 [15]. This evidence concerns the gene EGF and head and neck squamous cell carcinoma.